Bombay HC: Judicial Remand Extension Beyond 60 Days Without Hearing, Reasons is Illegal  ||  Telangana HC: Changing Arbitration Venue Without Consent is Legally Perversive  ||  J&K&L HC: Properly Addressed and Sent Notice Deemed Served Under General Clauses Act  ||  Jharkhand HC: Fresh Anticipatory Bail Plea Not Maintainable After Earlier Rejection under S. 482 BNSS  ||  Orissa HC: Res Judicata Principle Doesn’t Apply to Execution Proceedings under Order 21 CPC  ||  Orissa HC: Railways Strictly Liable for Passenger’s Death After Falling From Train  ||  Del. HC: Director Not Individually Liable for Asset Transfer Without Consideration under S.276 IT Act  ||  Delhi HC: No Blanket Protection for Litigants from Counsel’s Negligence  ||  Bombay HC: Board under Mathadi Act Has No Power to Review its Own Orders  ||  Delhi HC: Father Granted Custody When Mother’s Adultery Allegation Includes Neglect    

National Pharmaceutical Pricing Authority Notifies All Medical Devices Under Price Control - (02 Apr 2020)

LAW OF MEDICINE

National Pharmaceutical Pricing Authority has notified all medical devices sold in India as ‘drugs’ to bring the devices — such as syringes, needles, cardiac stents, a knee implant, digital thermometers, CT scan, MRIs and dialysis machines — under the purview of price control and prohibit firms from hiking their costs by more than 10% annually at a time.

Tags : NATIONAL PHARMACEUTICAL PRICING AUTHORITY   ALL MEDICAL DEVICES UNDER PRICE CONTROL  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved